JPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL IND
No trades
Key stats
About JPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL IND
Home page
Inception date
May 9, 2022
Structure
Open-Ended Fund
Replication method
Physical
Primary advisor
JPMorgan Asset Management (China) Co Ltd.
ISIN
CNE100005B86
Closely tracks the underlying index, and pursues the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.32%
Health Technology92.29%
Commercial Services7.03%
Bonds, Cash & Other0.68%
Cash0.68%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history